Sign In
Buy MAT
$14.13
-0.220 (-1.53%)
At Close: Jun 16, 2026
~39% Overall Response Rate (ORR): 1 CR and 6 PRs (2 awaiting confirmation) by RECIST 1.1 out of 18 evaluable MTAP-deletion urothelial and NSCLC patients ~94% Disease Control Rate (DCR): 1 CR and 6 PRs
Mattel doesn't need 'Barbie'-like returns for all its films: CEO
03:00pm, Thursday, 04'th Jul 2024
Mattel is still riding high following the success of Barbie. However, the toy company has 16 movies in development, with properties such as Masters of the Universe and Hot Wheels having projects in th
Mattel Announces Second Quarter 2024 Financial Results and Conference Call Date
04:05pm, Tuesday, 02'nd Jul 2024
EL SEGUNDO, Calif.--(BUSINESS WIRE)--Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its second quarter 2024 financial results on Tuesday, July 23, 2024, at approximately 4:05 p.m.
Mattel's UNO and other popular games will become colorblind accessible
12:25pm, Tuesday, 25'th Jun 2024
Mattel announced that 80% of its games will be colorblind accessible by the end of 2024. The company plans to raise this amount to 90% in 2025.
EL SEGUNDO, Calif.--(BUSINESS WIRE)--Mattel announces 80% of global games portfolio will be colorblind accessible by end of 2024 to support diverse, equitable, and inclusive communities.
BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies us
Targeting IDE397 Phase 2 monotherapy expansion dose clinical data update in over ~15 evaluable MTAP lung and bladder cancer patients in H2 2024, including RECIST 1.1 clinical efficacy waterfall, swim
Here's Why Mattel (MAT) is a Strong Value Stock
10:46am, Monday, 17'th Jun 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Matinas BioPharma's Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Expert Dr. David S.
07:00am, Thursday, 13'th Jun 2024
BEDMINSTER, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies us
EL SEGUNDO, Calif.--(BUSINESS WIRE)--The California State Legislature has recognized Mattel for its dedication to creating play experiences that bring joy and enrichment to children's lives as part of
Here's Why You Should Retain Mattel (MAT) Stock for Now
01:36pm, Monday, 10'th Jun 2024
Mattel's (MAT) focus on digital gaming and location-based entertainment will likely drive growth. However, an uncertain macroeconomic environment is a concern.
Mattel and Outright Games to Bring Matchbox Driving Adventures to Consoles and PC This September
05:30pm, Friday, 07'th Jun 2024
EL SEGUNDO, Calif. & LONDON--(BUSINESS WIRE)--Mattel, Inc. (Nasdaq: MAT), a leading global toy and family entertainment company and owner of one of the most iconic brand portfolios in the world, in co
Mattel (MAT) Partners Universal to Develop Monster High Movie
12:45pm, Thursday, 06'th Jun 2024
Mattel (MAT) teams up with Universal Pictures to develop a live-action feature film based on the teenage girl fashion doll line.
Mattel Films Partners with Universal Pictures and Akiva Goldsman for Monster High Feature Film
12:00pm, Wednesday, 05'th Jun 2024
EL SEGUNDO, Calif.--(BUSINESS WIRE)--Mattel, Inc. (NASDAQ: MAT) has partnered with Universal Pictures and Academy Award-winning producer/screenwriter Akiva Goldsman under his banner, Weed Road, to dev
Mattel Television Studios Announces New Animated Series, Barbie Mysteries: The Great Horse Chase to Debut on Netflix This Fall
11:00am, Thursday, 30'th May 2024
EL SEGUNDO, Calif.--(BUSINESS WIRE)--Mattel, Inc. (NASDAQ: MAT) today announced Barbie Mysteries: The Great Horse Chase, Mattel Television Studios' all-new animated children's series, will debut globa
